Fuss over medical marijuana
June 15, 2012 · Updated 10:51 AM
There is a good reason the governments are pushing back on medical marijuana collectives and dispensaries these days. They want to preserve a market share for new marijuana products with the aide of government influence.
In a subtle move by the DEA, marijuana derivatives were placed in schedule III of the Controlled Substances Act. The significance of this placement is that it cleared the way for new marijuana products, which feature CBD and CBN compounds previously unavailable for pharmaceutical giants to patent and market for sales.
The first of these drugs, Sativex, is already available outside the United States, and will be coming to America very shortly. The last thing the maker of Sativex wants is competition from the real thing, so the current medical marijuana genie must be put back into the bottle so Sativex can control the market share.
De Jure monopolies (government granted monopolies) are nothing new in America, and it comes as no surprise to those of us, members of the American public, who are more aware of the corporate influences on market share prices. I, for one, have come to accept this fact, albeit reluctantly.
Although the corporate and government control over market share prices is repugnant to me, even more repugnant is the lies we have been told for years about marijuana not having accepted medical use. Magically, with the appearance of Sativex and other similar drugs onto the market, marijuana will finally have accepted medical use.
How convenient. To have people thrown in jail and sucked up into the criminal justice snowball for no other reason than marijuana not being patentable and available for giant corporations to make a profit on goes beyond repugnance and instills rage.
So as the city, county, state and federal governments work to rid society of the evils of medical marijuana dispensaries and collectives, all of you well intentioned citizens need to know is that you are not helping cleanse your community, you are merely helping to preserve and drive up the market share price of Sativex and other direct derivatives and set the table for the end of the biggest lie in American history.
– John Worthington